• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    21 Stocks Moving in Thursday's Pre-Market Session

    12/9/21 7:30:02 AM ET
    $AVCT
    $BJDX
    $BKKT
    $CCNC
    EDP Services
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $AVCT alert in real time by email

    Gainers

    • Pear Therapeutics, Inc. (NASDAQ:PEAR) rose 64% to $15.20 in pre-market trading after climbing around 16% on Wednesday.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) rose 32.2% to $3.94 in pre-market trading. Ensysce Biosciences shares jumped 136% on Tuesday after Zacks Small-Cap Research set a $23 valuation on the stock.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 30.1% to $1.34 in pre-market trading after the company said it expects revenues of its Kandy Business Unit to increase from $14.3 million in 2020 to around $18.8 million in 2021 and in excess of $37 million in 2022.
    • Spruce Biosciences, Inc. (NASDAQ:SPRB) rose 28.6% to $3.50 in pre-market trading after gaining around 7% on Wednesday.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) rose 12.6% to $0.5210 in pre-market trading. TherapeuticsMD settled the previously disclosed U.S. patent litigation for Bijuva with Amneal Pharmaceuticals.
    • iSpecimen Inc. (NASDAQ:ISPC) rose 11.7% to $15.81 in pre-market trading after jumping more than 15% on Wednesday. iSpecimen recently announced expansion of supplier network of human biospecimens to help advance research in neurological disorders.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) rose 9.1% to $2.76 in pre-market trading. Digital Brands Group, last month, reported a Q3 loss of $0.76 per share.
    • Nuvei Corporation (NASDAQ:NVEI) rose 8.7% to $62.99 in pre-market trading. Nuvei reaffirmed its FY21 guidance.
    • New Oriental Education & Technology Group Inc. (NYSE:EDU) rose 7% to $2.30 in pre-market trading after gaining around 8% on Wednesday.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares rose 6.9% to $2.77 in pre-market trading. The company, last month, priced its IPO at $10 per unit.
    • Gaotu Techedu Inc.. (NYSE:GOTU) rose 5.4% to $2.55 in pre-market trading after gaining 11% on Wednesday.
    • Insignia Systems, Inc. (NASDAQ:ISIG) rose 6.2% to $20.30 in pre-market trading after climbing more than 84% on Wednesday. Insignia Systems recently announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Check out these big penny stock gainers and losers

    Losers

    • Code Chain New Continent Limited (NASDAQ:CCNC) fell 45.2% to $0.9317 in pre-market trading after jumping more than 20% on Wednesday.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares fell 38.3% to $33.58 in pre-market trading after the company announced outcome of FDA Advisory Committee Meeting of Bardoxolone for treatment of patients with chronic kidney disease caused by Alport syndrome. The company said committee voted 'no' on effective question.
    • Triterras, Inc. (NASDAQ:TRIT) shares fell 20.6% to $3.50 in pre-market trading after the company issued further update on Independent Audit of financials for fiscal year ended Feb. 28, 2021.
    • Bakkt Holdings, Inc. (NYSE:BKKT) fell 8.9% to $15.62 in pre-market trading after surging around 30% on Wednesday.
    • Pioneer Power Solutions, Inc. (NASDAQ:PPSI) shares fell 8% to $9.93 in pre-market trading after surging 34% on Wednesday.
    • Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) fell 7.1% to $0.7710 in pre-market trading after jumping around 32% on Wednesday. Idera Pharmaceuticals was recently granted European patent titled 'Treatment Of Cancer Using Tlr9 Agonists And Checkpoint Inhibitors.'
    • Phunware, Inc. (NASDAQ:PHUN) fell 6.9% to $3.64 in pre-market trading after surging 21% on Wednesday.
    • ATRenew Inc. (NYSE:RERE) fell 6.3% to $6.00 in pre-market trading.
    • CF Acquisition Corp. VI (NASDAQ:CFVI) shares fell 6.2% to $14.06 in pre-market trading after gaining over 14% on Wednesday.
    Get the next $AVCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVCT
    $BJDX
    $BKKT
    $CCNC

    CompanyDatePrice TargetRatingAnalyst
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    1/28/2026Hold → Buy
    HSBC Securities
    Spruce Biosciences Inc.
    $SPRB
    12/23/2025$283.00Outperform
    Oppenheimer
    Spruce Biosciences Inc.
    $SPRB
    12/3/2025$160.00Market Perform → Outperform
    Leerink Partners
    Spruce Biosciences Inc.
    $SPRB
    10/28/2025$254.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Bakkt Inc.
    $BKKT
    9/8/2025$13.00Buy
    The Benchmark Company
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    8/6/2025$50.00Buy → Neutral
    Goldman
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    7/30/2025Buy → Hold
    HSBC Securities
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    6/27/2025$50.00Neutral → Buy
    Citigroup
    More analyst ratings

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2026

    BEIJING, April 22, 2026 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results for the third fiscal quarter ended February 28, 2026, which is the third quarter of New Oriental's fiscal year 2026. Financial Highlights for the Third Fiscal Quarter Ended February 28, 2026Total net revenues increased by 19.8% year over year to US$1,417.3 million for the third fiscal quarter of 2026. Operating income increased by 44.8% year over year to US$180.3 million for the third fiscal quarter of 2026.Net income attributable to New Oriental inc

    4/22/26 5:00:00 AM ET
    $EDU
    Other Consumer Services
    Real Estate

    Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

    Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the pricing of its previously announced underwritten public offering of 1,150,000 shares of its common stock at a price to the public of $50.00 per share and, in lieu of shares of common stock to a certain investor, pre-funded warrants to purchase 50,000 shares of common stock at a purchase price of $49.99 per share, which equals the public offering price per share of the common stock less the $0.01 exercise price per share of each pre-funded warrant. T

    4/20/26 11:45:00 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

    Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it has commenced an underwritten public offering of shares of its common stock or pre-funded warrants to purchase shares of its common stock in lieu thereof. All of the securities are being offered by Spruce Biosciences. In addition, Spruce Biosciences expects to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount of up to 15% of the aggregate number of shares sold in the offering at the public offeri

    4/20/26 4:01:00 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    New Oriental Education & Technology upgraded by HSBC Securities

    HSBC Securities upgraded New Oriental Education & Technology from Hold to Buy

    1/28/26 3:01:34 PM ET
    $EDU
    Other Consumer Services
    Real Estate

    Oppenheimer initiated coverage on Spruce Biosciences with a new price target

    Oppenheimer initiated coverage of Spruce Biosciences with a rating of Outperform and set a new price target of $283.00

    12/23/25 8:47:57 AM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Spruce Biosciences upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Spruce Biosciences from Market Perform to Outperform and set a new price target of $160.00

    12/3/25 8:26:32 AM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    SEC Filings

    View All

    SEC Form 6-K filed by New Oriental Education & Technology Group Inc. Sponsored ADR r

    6-K - New Oriental Education & Technology Group Inc. (0001372920) (Filer)

    4/22/26 9:26:01 AM ET
    $EDU
    Other Consumer Services
    Real Estate

    Spruce Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - SPRUCE BIOSCIENCES, INC. (0001683553) (Filer)

    4/21/26 5:50:42 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Digital Brands Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Digital Brands Group, Inc. (0001668010) (Filer)

    4/21/26 5:28:29 PM ET
    $DBGI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Mazurek Nathan bought $33,870 worth of shares (10,000 units at $3.39), increasing direct ownership by 0.51% to 1,976,496 units (SEC Form 4)

    4 - PIONEER POWER SOLUTIONS, INC. (0001449792) (Issuer)

    11/20/25 4:05:04 PM ET
    $PPSI
    Electrical Products
    Industrials

    Large owner Parkman Healthcare Partners Llc bought $4,585 worth of shares (256 units at $17.91) and sold $4,920 worth of shares (257 units at $19.14) (SEC Form 4)

    4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)

    10/15/25 4:32:43 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Baes Nicholas

    4 - Bakkt, Inc. (0001820302) (Issuer)

    4/8/26 6:31:27 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Du Quyen

    4 - Phunware, Inc. (0001665300) (Issuer)

    4/7/26 9:05:03 PM ET
    $PHUN
    EDP Services
    Technology

    SEC Form 4 filed by Han Elliot Jin

    4 - Phunware, Inc. (0001665300) (Issuer)

    4/7/26 9:00:05 PM ET
    $PHUN
    EDP Services
    Technology

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Leadership Updates

    Live Leadership Updates

    View All

    UPDATE - Bakkt Releases Shareholder Letter and Reports Full Year 2025 Financial Results

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today released a shareholder letter from Chief Executive Officer Akshay Naheta and reported its financial results for the full year ended December 31, 2025. The Company will discuss its results and 2026 strategic priorities at its Investor Day on March 17, 2026. To our Shareholders: Dear Fellow Shareholders, I am writing to you for the first time as CEO of Bakkt. When I joined the company, it was clear that significant rebuilding was required. Bakkt possessed something rare — a deep regulatory foundation and institutional pedigree rooted in its origins within Intercontinental Exchange — but

    3/16/26 6:49:34 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Bakkt Releases Shareholder Letter and Reports Full Year 2025 Financial Results

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today released a shareholder letter from Chief Executive Officer Akshay Naheta and reported its financial results for the full year ended December 31, 2025. The Company will discuss its results and 2026 strategic priorities at its Investor Day on March 17, 2026. To our Shareholders: Dear Fellow Shareholders, I am writing to you for the first time as CEO of Bakkt. When I joined the company, it was clear that significant rebuilding was required. Bakkt possessed something rare — a deep regulatory foundation and institutional pedigree rooted in its origins within Intercontinental Exchange — but

    3/16/26 6:09:59 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates

    Following Positive Type B Meetings with the FDA, BLA Submission for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) on Track for the Fourth Quarter of 2026 Appoints Dale Hooks as Chief Commercial Officer, Strengthening the Company's Commercial Capabilities in Preparation for a Potential Launch of TA-ERT Secured up to $50 Million in Growth Capital from Avenue Capital Group Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the year ended December 31, 2025 and provided corporate update

    3/9/26 7:05:00 AM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Financials

    Live finance-specific insights

    View All

    New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2026

    BEIJING, April 22, 2026 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results for the third fiscal quarter ended February 28, 2026, which is the third quarter of New Oriental's fiscal year 2026. Financial Highlights for the Third Fiscal Quarter Ended February 28, 2026Total net revenues increased by 19.8% year over year to US$1,417.3 million for the third fiscal quarter of 2026. Operating income increased by 44.8% year over year to US$180.3 million for the third fiscal quarter of 2026.Net income attributable to New Oriental inc

    4/22/26 5:00:00 AM ET
    $EDU
    Other Consumer Services
    Real Estate

    Pioneer Power Announces Financial Results for Fourth Quarter and Full Year 2025

    Full Year Revenue of $27.6 Million, Up 21% and In-line with Guidance Pioneer Power Solutions, Inc. (NASDAQ:PPSI) ("Pioneer" or the "Company"), a leader in the design, manufacture, service and integration of distributed energy resources, power generation equipment and mobile electric vehicle ("EV") charging solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Strategic Business Highlights Global Expansion of e-Boost Ecosystem: Successfully entered a strategic international agreement to scale e-Boost mobile charging technology globally. By leveraging a high-margin franchise model and local partnerships, the Company is preparing

    4/8/26 4:35:00 PM ET
    $PPSI
    Electrical Products
    Industrials

    New Oriental to Report Third Quarter 2026 Financial Results on April 22, 2026

    BEIJING, March 31, 2026 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE:EDU), a provider of private educational services in China, today announced that it will report its financial results for the third quarter ended February 28, 2026, before the U.S. market opens on April 22, 2026. New Oriental's management will host an earnings conference call at 8 AM on April 22, 2026, U.S. Eastern Time (8 PM on April 22, 2026, Beijing/Hong Kong Time). Participants can join the conference using the below options: Dialling-in to the conference call:Please register in advance of the conference, using the link provided below. Upon registering, you will

    3/31/26 5:00:00 AM ET
    $EDU
    Other Consumer Services
    Real Estate

    $AVCT
    $BJDX
    $BKKT
    $CCNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nuvei Corporation Subordinate Voting Shares

    SC 13D/A - Nuvei Corp (0001765159) (Subject)

    11/15/24 4:59:27 PM ET
    $NVEI
    Business Services
    Consumer Discretionary

    SEC Form SC 13G filed by Ensysce Biosciences Inc.

    SC 13G - Ensysce Biosciences, Inc. (0001716947) (Subject)

    11/14/24 5:52:56 PM ET
    $ENSC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Bluejay Diagnostics Inc.

    SC 13G - Bluejay Diagnostics, Inc. (0001704287) (Subject)

    11/14/24 5:49:49 PM ET
    $BJDX
    Medical/Dental Instruments
    Health Care